Chapter 2 Third‐Generation Flavivirus Vaccines Based on Single‐Cycle, Encapsidation‐Defective Viruses
- 9 December 2008
- book chapter
- Published by Elsevier
- Vol. 72, 77-126
- https://doi.org/10.1016/s0065-3527(08)00402-8
Abstract
No abstract availableKeywords
This publication has 200 references indexed in Scilit:
- Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteersVaccine, 2008
- Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4Vaccine, 2007
- DengueThe Lancet, 2007
- Preparation and immunogenic properties of a recombinant West Nile subunit vaccineVaccine, 2006
- Production and characterization of vaccines based on flaviviruses defective in replicationVirology, 2006
- A live, attenuated recombinant West Nile virus vaccineProceedings of the National Academy of Sciences, 2006
- Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersVaccine, 2001
- Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213Virus Research, 1995
- Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cellsArchiv für die gesamte Virusforschung, 1994
- Protection against Japanese Encephalitis by Inactivated VaccinesNew England Journal of Medicine, 1988